Lisa Bright
CIK 1635111 · President, International · last filed 2020-07-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
1
Total Filings
49
Lifetime Open-Market Net
-$2.05M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | President, International | 22,012 | $19.00 | $418.2K | -$2.05M | 43 | 2020-07-06 |
Recent Filings · Page 2 of 5
49 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-10-31 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Sell (S) | −595 | -$44.6K | EDGAR |
| 2019-10-03 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Tax (F) | −530 | -$34.9K | EDGAR |
| 2019-07-03 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Mixed | −1,125 | -$88.8K | EDGAR |
| 2019-04-03 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Mixed | −1,125 | -$127.5K | EDGAR |
| 2019-01-18 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Grant (A) | +3,300 | $0 | EDGAR |
| 2019-01-09 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Sell (S) | −1,313 | -$137.8K | EDGAR |
| 2019-01-03 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Tax (F) | −1,168 | -$117.7K | EDGAR |
| 2018-12-06 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Sell (S) | −5,000 | -$557.1K | EDGAR |
| 2018-11-27 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Tax (F) | −247 | -$27.4K | EDGAR |
| 2018-10-03 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Mixed | −3,850 | -$348.3K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.